{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T06:10:04Z","timestamp":1778393404398,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009233","name":"College of Pharmacy, University of Minnesota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009233","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL151740"],"award-info":[{"award-number":["R01HL151740"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL151740"],"award-info":[{"award-number":["R01HL151740"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000885","name":"Children\u2019s Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000885","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-98617-5","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T14:41:58Z","timestamp":1746283318000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Divergent immediate and delayed effects of juvenile exposure to doxorubicin on the thymus in C57BL\/6 mice"],"prefix":"10.1038","volume":"15","author":[{"given":"Benu","family":"George","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Korbyn J. V.","family":"Dahlquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne K. O.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary R.","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Declan M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Ahlberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim T.","family":"Sadak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davis","family":"Seelig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina D.","family":"Camell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beshay N.","family":"Zordoky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,3]]},"reference":[{"key":"98617_CR1","doi-asserted-by":"publisher","first-page":"14649","DOI":"10.3390\/ijms232314649","volume":"23","author":"A Bhagat","year":"2022","unstructured":"Bhagat, A., Shrestha, P. & Kleinerman, E. S. The innate immune system in cardiovascular diseases and its role in doxorubicin-induced cardiotoxicity. Int. J. Mol. Sci. 23, 14649 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"98617_CR2","doi-asserted-by":"publisher","first-page":"933547","DOI":"10.3389\/fimmu.2022.933547","volume":"13","author":"MK Lagou","year":"2022","unstructured":"Lagou, M. K., Anastasiadou, D. P. & Karagiannis, G. S. A proposed link between acute thymic Involution and late adverse effects of chemotherapy. Front. Immunol. 13, 933547 (2022).","journal-title":"Front. Immunol."},{"key":"98617_CR3","doi-asserted-by":"publisher","first-page":"1168186","DOI":"10.3389\/fendo.2023.1168186","volume":"14","author":"W Savino","year":"2023","unstructured":"Savino, W. & Lepletier, A. Thymus-derived hormonal and cellular control of cancer. Front. Endocrinol. 14, 1168186 (2023).","journal-title":"Front. Endocrinol."},{"key":"98617_CR4","doi-asserted-by":"publisher","first-page":"6232","DOI":"10.1021\/pr100465m","volume":"9","author":"R Sultana","year":"2010","unstructured":"Sultana, R. et al. Doxorubicin-induced thymus senescence. J. Proteome Res. 9, 6232\u20136241 (2010).","journal-title":"J. Proteome Res."},{"key":"98617_CR5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.immuni.2018.01.007","volume":"48","author":"BV Kumar","year":"2018","unstructured":"Kumar, B. V., Connors, T. J. & Farber, D. L. Human T- cell development, localization, and function throughout life. Immunity 48, 202\u2013213 (2018).","journal-title":"Immunity"},{"key":"98617_CR6","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1172\/JCI200522492","volume":"115","author":"FT Hakim","year":"2005","unstructured":"Hakim, F. T. et al. Age-dependent incidence, time course, and consequences of thymic renewal in adults. J. Clin. Invest. 115, 930\u2013939 (2005).","journal-title":"J. Clin. Invest."},{"key":"98617_CR7","doi-asserted-by":"crossref","unstructured":"Sun, D. P. et al. Thymic hyperplasia after chemotherapy in adults with mature B cell lymphoma and its influence on thymic output and CD4(+) T- cells repopulation. Oncoimmunology 5, e1137417 (2016).","DOI":"10.1080\/2162402X.2015.1137417"},{"key":"98617_CR8","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1365-2362.2005.01499.x","volume":"35","author":"PP Sfikakis","year":"2005","unstructured":"Sfikakis, P. P. et al. Age-related thymic activity in adults following chemotherapy\u2010induced lymphopenia. Eur. J. Clin. Invest. 35, 380\u2013387 (2005).","journal-title":"Eur. J. Clin. Invest."},{"key":"98617_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1056\/NEJM199501193320303","volume":"332","author":"CL Mackall","year":"1995","unstructured":"Mackall, C. L. et al. Age, thymopoiesis, and CD4\u2009+\u2009T-lymphocyte regeneration after intensive chemotherapy. N Engl. J. Med. 332, 143\u2013149 (1995).","journal-title":"N Engl. J. Med."},{"key":"98617_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2214\/ajr.149.2.269","volume":"149","author":"PL Choyke","year":"1987","unstructured":"Choyke, P. L. et al. Thymic atrophy and regrowth in response to chemotherapy: CT evaluation. AJR Am. J. Roentgenol. 149, 269\u2013272 (1987).","journal-title":"AJR Am. J. Roentgenol."},{"key":"98617_CR11","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.coph.2010.04.006","volume":"10","author":"TSP Heng","year":"2010","unstructured":"Heng, T. S. P., Chidgey, A. P. & Boyd, R. L. Getting back at nature: Understanding thymic development and overcoming its atrophy. Curr. Opin. Pharmacol. 10, 425\u2013433 (2010).","journal-title":"Curr. Opin. Pharmacol."},{"key":"98617_CR12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.37349\/ei.2024.00134","volume":"4","author":"MPD Aguiar","year":"2024","unstructured":"Aguiar, M. P. D. & Vieira, J. H. Entrance to the multifaceted world of CD4\u2009+\u2009T-cell subsets. Explor. Immunol. 4, 152\u2013168 (2024).","journal-title":"Explor. Immunol."},{"key":"98617_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-1-4939-2809-5_4","volume":"1323","author":"JYM Lee","year":"2016","unstructured":"Lee, J. Y. M. & Love, P. E. Assessment of T- cell development by flow cytometry. Methods Mol. Biol. Clifton NJ. 1323, 47\u201364 (2016).","journal-title":"Methods Mol. Biol. Clifton NJ"},{"key":"98617_CR14","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3389\/fimmu.2020.00487","volume":"11","author":"JM Jubel","year":"2020","unstructured":"Jubel, J. M. et al. The role of PD-1 in acute and chronic infection. Front. Immunol. 11, 487 (2020).","journal-title":"Front. Immunol."},{"key":"98617_CR15","doi-asserted-by":"publisher","first-page":"eabd2712","DOI":"10.1126\/sciadv.abd2712","volume":"6","author":"N Patsoukis","year":"2020","unstructured":"Patsoukis, N. et al. Revisiting the PD-1 pathway. Sci. Adv. 6, eabd2712 (2020).","journal-title":"Sci. Adv."},{"key":"98617_CR16","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1002\/cam4.3788","volume":"10","author":"J Sulicka-Grodzicka","year":"2021","unstructured":"Sulicka-Grodzicka, J. et al. Low-grade chronic inflammation and immune alterations in childhood and adolescent cancer survivors: A contribution to accelerated aging? Cancer Med. 10, 1772\u20131782 (2021).","journal-title":"Cancer Med."},{"key":"98617_CR17","doi-asserted-by":"publisher","first-page":"1189015","DOI":"10.3389\/fonc.2023.1189015","volume":"13","author":"S Xiao","year":"2023","unstructured":"Xiao, S. et al. Cellular senescence: a double-edged sword in cancer therapy. Front. Oncol. 13, 1189015 (2023).","journal-title":"Front. Oncol."},{"key":"98617_CR18","doi-asserted-by":"publisher","first-page":"R685","DOI":"10.1152\/ajpregu.00082.2014","volume":"307","author":"K Sturgeon","year":"2014","unstructured":"Sturgeon, K. et al. Concomitant low-dose doxorubicin treatment and exercise. Am. J. Physiol. Regul. Integr. Comp. Physiol. 307, R685\u2013692 (2014).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"98617_CR19","doi-asserted-by":"publisher","first-page":"9023","DOI":"10.3390\/ijms22169023","volume":"22","author":"IY Abdelgawad","year":"2021","unstructured":"Abdelgawad, I. Y., Grant, M. K. O., Popescu, F. E., Largaespada, D. A. & Zordoky, B. N. Doxorubicin paradoxically ameliorates tumor-induced inflammation in young mice. Int. J. Mol. Sci. 22, 9023 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"98617_CR20","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3390\/ph16030391","volume":"16","author":"K Agostinucci","year":"2023","unstructured":"Agostinucci, K., Grant, M. K. O., Melaku, W., Nair, C. & Zordoky, B. N. Exposure to doxorubicin modulates the cardiac response to isoproterenol in male and female mice. Pharmaceuticals 16, 391 (2023).","journal-title":"Pharmaceuticals"},{"key":"98617_CR21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3389\/fimmu.2013.00187","volume":"4","author":"R Romano","year":"2013","unstructured":"Romano, R. et al. Foxn1: a master regulator gene of thymic epithelial development program. Front. Immunol. 4, 187 (2013).","journal-title":"Front. Immunol."},{"key":"98617_CR22","first-page":"23","volume":"122","author":"J Wallin","year":"1996","unstructured":"Wallin, J. et al. Pax1 is expressed during development of the thymus epithelium and is required for normal T-cell maturation. Dev. Camb. Engl. 122, 23\u201330 (1996).","journal-title":"Dev. Camb. Engl."},{"key":"98617_CR23","first-page":"3310","volume":"145","author":"PT Le","year":"1990","unstructured":"Le, P. T. et al. Human thymic epithelial cells produce IL-6, granulocyte-monocyte-CSF, and leukemia inhibitory factor. J. Immunol. Baltim. Md. 1950. 145, 3310\u20133315 (1990).","journal-title":"J. Immunol. Baltim. Md. 1950"},{"key":"98617_CR24","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1084\/jem.174.5.1147","volume":"174","author":"PT Le","year":"1991","unstructured":"Le, P. T., Lazorick, S., Whichard, L. P., Haynes, B. F. & Singer, K. H. Regulation of cytokine production in the human thymus: epidermal growth factor and transforming growth factor alpha regulate mRNA levels of Interleukin 1 alpha (IL-1 alpha), IL-1 beta, and IL-6 in human thymic epithelial cells at a post-transcriptional level. J. Exp. Med. 174, 1147\u20131157 (1991).","journal-title":"J. Exp. Med."},{"key":"98617_CR25","first-page":"2704","volume":"158","author":"KS Schluns","year":"1997","unstructured":"Schluns, K. S., Cook, J. E. & Le, P. T. TGF-beta differentially modulates epidermal growth factor-mediated increases in leukemia-inhibitory factor, IL-6, IL-1 alpha, and IL-1 beta in human thymic epithelial cells. J. Immunol. Baltim. Md. 1950. 158, 2704\u20132712 (1997).","journal-title":"J. Immunol. Baltim. Md. 1950"},{"key":"98617_CR26","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S2352-4642(20)30312-6","volume":"5","author":"GMT Guilcher","year":"2021","unstructured":"Guilcher, G. M. T. et al. Immune function in childhood cancer survivors: a children\u2019s oncology group review. Lancet Child. Adolesc. Health. 5, 284\u2013294 (2021).","journal-title":"Lancet Child. Adolesc. Health"},{"key":"98617_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41416-018-0155-1","volume":"120","author":"S Khan","year":"2019","unstructured":"Khan, S. et al. Immune dysregulation in cancer patients developing immune-related adverse events. Br. J. Cancer. 120, 63\u201368 (2019).","journal-title":"Br. J. Cancer"},{"key":"98617_CR28","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.3389\/fimmu.2019.01719","volume":"10","author":"A Xia","year":"2019","unstructured":"Xia, A., Zhang, Y., Xu, J., Yin, T. & Lu, X. J. T- cell dysfunction in cancer immunity and immunotherapy. Front. Immunol. 10, 1719 (2019).","journal-title":"Front. Immunol."},{"key":"98617_CR29","doi-asserted-by":"publisher","first-page":"e557s","DOI":"10.6061\/clinics\/2018\/e557s","volume":"73","author":"H de Carvalho","year":"2018","unstructured":"de Carvalho, H., Villar, R. C. & A. & Radiotherapy and immune response: the systemic effects of a local treatment. Clin. Sao Paulo Braz. 73, e557s (2018).","journal-title":"Clin. Sao Paulo Braz"},{"key":"98617_CR30","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1158\/1541-7786.MCR-18-0308","volume":"16","author":"O Sizova","year":"2018","unstructured":"Sizova, O., Kuriatnikov, D., Liu, Y. & Su, D. M. Atrophied thymus, a tumor reservoir for harboring melanoma cells. Mol. Cancer Res. 16, 1652\u20131664 (2018).","journal-title":"Mol. Cancer Res."},{"key":"98617_CR31","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1177\/1534735415617014","volume":"15","author":"CJ Quinn","year":"2016","unstructured":"Quinn, C. J. et al. Effects of chronic endurance exercise on doxorubicin-induced thymic damage. Integr. Cancer Ther. 15, 535\u2013541 (2016).","journal-title":"Integr. Cancer Ther."},{"key":"98617_CR32","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.intimp.2009.09.008","volume":"9","author":"JY Park","year":"2009","unstructured":"Park, J. Y. et al. Doxorubicin enhances CD4(+) T-cell immune responses by inducing expression of CD40 ligand and 4-1BB. Int. Immunopharmacol. 9, 1530\u20131539 (2009).","journal-title":"Int. Immunopharmacol."},{"key":"98617_CR33","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1158\/0008-5472.CAN-13-1545","volume":"74","author":"D Alizadeh","year":"2014","unstructured":"Alizadeh, D. et al. Doxorubicin eliminates myeloid-derived suppressor cells and enhances the efficacy of adoptive T-cell transfer in breast cancer. Cancer Res. 74, 104\u2013118 (2014).","journal-title":"Cancer Res."},{"key":"98617_CR34","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.3390\/app12073652","volume":"12","author":"I Kwon","year":"2022","unstructured":"Kwon, I., Go, G. W., Lee, Y. & Kim, J. H. Prolonged endurance exercise adaptations counteract doxorubicin chemotherapy-induced myotoxicity in mice. Appl. Sci. 12, 3652 (2022).","journal-title":"Appl. Sci."},{"key":"98617_CR35","doi-asserted-by":"publisher","first-page":"303","DOI":"10.5152\/TurkThoracJ.2020.18163","volume":"21","author":"S Deniz","year":"2020","unstructured":"Deniz, S. et al. Effect of rebound thymic hyperplasia on survival in chemotherapy-treated lung cancer. Turk. Thorac. J. 21, 303\u2013307 (2020).","journal-title":"Turk. Thorac. J."},{"key":"98617_CR36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12893-021-01048-y","volume":"21","author":"L Qiu","year":"2021","unstructured":"Qiu, L. et al. Thymic rebound hyperplasia post-chemotherapy mistaken as disease progression in a patient with lymphoma involving mediastinum: a case report and reflection. BMC Surg. 21, 38 (2021).","journal-title":"BMC Surg."},{"key":"98617_CR37","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.4049\/jimmunol.1800016","volume":"201","author":"B Li","year":"2018","unstructured":"Li, B., Jones, L. L. & Geiger, T. L. IL-6 promotes T- cell proliferation and expansion under inflammatory conditions in association with low-level ROR\u03b3t expression. J. Immunol. 201, 2934\u20132946 (2018).","journal-title":"J. Immunol."},{"key":"98617_CR38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cyto.2016.08.027","volume":"101","author":"WY Tseng","year":"2018","unstructured":"Tseng, W. Y. et al. TNFR signalling and its clinical implications. Cytokine 101, 19\u201325 (2018).","journal-title":"Cytokine"},{"key":"98617_CR39","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/s41385-022-00519-6","volume":"15","author":"B Kapse","year":"2022","unstructured":"Kapse, B. et al. Age-dependent rise in IFN-\u03b3 competence undermines effective type 2 responses to nematode infection. Mucosal Immunol. 15, 1270\u20131282 (2022).","journal-title":"Mucosal Immunol."},{"key":"98617_CR40","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/ni.1783","volume":"10","author":"BR Marks","year":"2009","unstructured":"Marks, B. R. et al. Thymic self-reactivity selects natural Interleukin 17-producing T-cells that can regulate peripheral inflammation. Nat. Immunol. 10, 1125\u20131132 (2009).","journal-title":"Nat. Immunol."},{"key":"98617_CR41","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cyto.2013.03.026","volume":"62","author":"D Levi","year":"2013","unstructured":"Levi, D. & Polychronakos, C. Self-antigen expression in thymic epithelial cells in IFN-\u03b3 or TNF-\u03b1 deficiency. Cytokine 62, 433\u2013438 (2013).","journal-title":"Cytokine"},{"key":"98617_CR42","doi-asserted-by":"publisher","first-page":"e288","DOI":"10.1002\/mco2.288","volume":"4","author":"J Shen","year":"2023","unstructured":"Shen, J., Wang, Q., Mao, Y., Gao, W. & Duan, S. Targeting the p53 signaling pathway in cancers: molecular mechanisms and clinical studies. MedComm 4, e288 (2023).","journal-title":"MedComm"},{"key":"98617_CR43","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.3390\/cells9051186","volume":"9","author":"S Pisonero-Vaquero","year":"2020","unstructured":"Pisonero-Vaquero, S., Soldati, C., Cesana, M., Ballabio, A. & Medina, D. L. TFEB modulates p21\/WAF1\/CIP1 during the DNA damage response. Cells 9, 1186 (2020).","journal-title":"Cells"},{"key":"98617_CR44","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/cdd.2016.123","volume":"24","author":"M Pinto","year":"2017","unstructured":"Pinto, M. et al. Transient mitochondrial DNA double strand breaks in mice cause accelerated aging phenotypes in a ROS-dependent but p53\/p21-independent manner. Cell. Death Differ. 24, 288\u2013299 (2017).","journal-title":"Cell. Death Differ."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98617-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98617-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98617-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T16:02:42Z","timestamp":1746288162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98617-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,3]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["98617"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-98617-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.08.21.609003","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,3]]},"assertion":[{"value":"20 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15557"}}